VeriSIM Case Studies & White Papers │ Drug Discovery & Development Technology

Pathways for Successful AI Adoption in Drug Development

Artificial intelligence in drug development has transformative potential when it comes to pharma research and development (R&D). Download the white paper to advance the adoption of AI within your organization.

Frost & Sullivan Report: AI-enabled Preclinical Development, VeriSIM Life

12/13/2022

Frost & Sullivan 2022 Competitive Strategy Leader Award North American Artificial Intelligence Enabled Preclinical Development Industry

Optimizing Stratified Dosing for Diabetic Patients With a Novel Computational Platform

09.28.2020

This study covers one of the many applications of BIOiSIM. Our aim was to establish what the pharmacokinetic (PK) profile would look like in the different subjects studied.

BIOiSIM™ Drug Decision Engine: Breakthrough Intelligence to De-risk R&D Translation, Without Disruption

09.30.2022

This white paper showcases how fusing artificial intelligence and mechanistic modeling can be used to accurately predict the disposition of small molecules across different subjects for translation to clinical success.

Novel Computational Platform Successfully Simulates Transdermal Drug Permeation

07.22.2020

This study covers the development and validation of a transdermal model using the BIOiSIM framework, which was further used to describe the relationship between compound exposure and therapeutic effect.

Translational Prediction of Drug Disposition Using an AI-Integrated Computational Platform

05.06.2020